cosinuss° joins DiME’s DATAcc project “Building the Business Case for Digital Endpoints” to revolutionize clinical trials
Posted:
DATAcc by DiMe launches its new project, “Building the Business Case for Digital Endpoints,” aimed at advancing the adoption of digital health measures in clinical trials. Read the full article here.
Waystar has signed a definitive agreement to acquire Iodine Software, a $1.25 billion deal that seeks to empower healthcare payments with more AI capabilities.
Read more here.
Doctors will be able to prescribe a new treatment for people with inflammatory bowel disease (IBD), after the UK medicines watchdog approved guselkumab (Tremfya) for use on the NHS.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us